scholarly article | Q13442814 |
P819 | ADS bibcode | 2004PNAS..101.1589Z |
P356 | DOI | 10.1073/PNAS.0305802101 |
P932 | PMC publication ID | 341781 |
P698 | PubMed publication ID | 14757825 |
P5875 | ResearchGate publication ID | 8890299 |
P2093 | author name string | Anthony W Norman | |
Laura P Zanello | |||
P2860 | cites work | Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches | Q22337395 |
Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects | Q24555101 | ||
The nuclear receptor superfamily: the second decade | Q27860725 | ||
Nuclear-receptor ligands and ligand-binding domains | Q28139440 | ||
Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity | Q28205398 | ||
Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning | Q28508915 | ||
Fast insulin secretion reflects exocytosis of docked granules in mouse pancreatic B-cells | Q30834291 | ||
Rapid actions of steroid receptors in cellular signaling pathways. | Q34135517 | ||
Nuclear receptors, coactivators and chromatin: new approaches, new insights | Q34276963 | ||
Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model | Q34288117 | ||
Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors | Q34386364 | ||
Navigating steroid hormone receptors through the nuclear compartment | Q34712990 | ||
Nongenomic steroid action: controversies, questions, and answers | Q35169916 | ||
Estimation of mean exocytic vesicle capacitance in mouse adrenal chromaffin cells | Q36239491 | ||
Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia | Q36576317 | ||
Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane | Q39740320 | ||
Structure-function relationships in the vitamin D endocrine system | Q40545127 | ||
Evidence for distinct membrane receptors for 1 alpha,25-(OH)(2)D(3) and 24R,25-(OH)(2)D(3) in osteoblasts | Q40749428 | ||
Stimulation by 1alpha,25(OH)2-vitamin D3 of whole cell chloride currents in osteoblastic ROS 17/2.8 cells. A structure-function study | Q41091803 | ||
Further analysis of spontaneous membrane potential activity and the hyperpolarizing response to parathyroid hormone in osteoblastlike cells | Q41370264 | ||
Vitamin D3 metabolites modulate dihydropyridine-sensitive calcium currents in clonal rat osteosarcoma cells. | Q41758627 | ||
Control of intracellular pH in rat calvarial osteoblasts: coexistence of both chloride-bicarbonate and sodium-hydrogen exchange | Q42208991 | ||
Identification of a membrane receptor for 1,25-dihydroxyvitamin D3 which mediates rapid activation of protein kinase C. | Q42461124 | ||
Identification of a specific binding protein for 1 alpha,25-dihydroxyvitamin D3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia | Q42497305 | ||
Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements | Q42516468 | ||
Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage | Q43726296 | ||
ERbeta has nongenomic action in caveolae | Q43974252 | ||
Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. | Q44044824 | ||
1,25(OH)2-vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells | Q44060028 | ||
A specific binding protein/receptor for 1alpha,25-dihydroxyvitamin D(3) is present in an intestinal caveolae membrane fraction | Q44203332 | ||
Stimulation of phosphorylation of mitogen-activated protein kinase by 1alpha,25-dihydroxyvitamin D3 in promyelocytic NB4 leukemia cells: a structure-function study | Q44214344 | ||
Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor | Q44292785 | ||
Multiple molecular mechanisms of 1 alpha,25(OH)2-vitamin D3 rapid modulation of three ion channel activities in osteoblasts | Q44550174 | ||
Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3. | Q45983702 | ||
Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses | Q46290644 | ||
Capacitance steps and fusion pores of small and large-dense-core vesicles in nerve terminals | Q48560522 | ||
Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets | Q50335713 | ||
Calcium regulates exocytosis at the level of single vesicles. | Q53859233 | ||
Potassium currents and effects of vitamin D-3 metabolites and cyclic GMP in rat osteoblastic cells | Q70458153 | ||
Localization of Ca2+ extrusion sites in pancreatic acinar cells | Q71081510 | ||
An insulinotropic effect of vitamin D analog with increasing intracellular Ca2+ concentration in pancreatic beta-cells through nongenomic signal transduction | Q73025301 | ||
Altered expression of bone sialoproteins in vitamin D-deficient rBSP2.7Luc transgenic mice | Q77953551 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | vitamin D | Q175621 |
osteoblast | Q917177 | ||
P1104 | number of pages | 6 | |
P304 | page(s) | 1589-1594 | |
P577 | publication date | 2004-02-02 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Rapid modulation of osteoblast ion channel responses by 1alpha,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor | |
P478 | volume | 101 |
Q46493611 | 1,25-dihydroxyvitamin D3 modulation of adipocyte glucocorticoid function. |
Q42450992 | 1alpha,25(OH)(2) vitamin D(3) induction of ATP secretion in osteoblasts |
Q40185750 | 1alpha,25(OH)2-vitamin D3 membrane-initiated calcium signaling modulates exocytosis and cell survival |
Q40148790 | 1alpha,25-Dihydroxyvitamin D(3) antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21(waf1) upregulation in human osteosarcoma |
Q38897681 | 25-Hydroxycholecalciferol Enhances Male Broiler Breast Meat Yield through the mTOR Pathway. |
Q34708522 | Classic versus non-classic receptors for nongenomic mineralocorticoid responses: emerging evidence |
Q46822790 | Differential regulation of extracellular signal-related kinase phosphorylation by vitamin D3 analogs |
Q24600470 | GADD45γ: a New Vitamin D-Regulated Gene that Is Antiproliferative in Prostate Cancer Cells |
Q38072903 | Gastric acid, calcium absorption, and their impact on bone health |
Q37511791 | Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling |
Q26801494 | Immune Modulation by Vitamin D and Its Relevance to Food Allergy |
Q37838145 | Is vitamin D deficiency associated with heart failure? A review of current evidence |
Q64067392 | Mechanisms of vitamin D on skeletal muscle function: oxidative stress, energy metabolism and anabolic state |
Q39137422 | Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors. |
Q38331408 | Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases |
Q45953618 | Opening of chloride channels by 1α,25-dihydroxyvitamin D3 contributes to photoprotection against UVR-induced thymine dimers in keratinocytes. |
Q33710174 | Pathogenic roles of alterations in vitamin D and vitamin D receptor in gastric tumorigenesis |
Q36682230 | Potent 19-norvitamin D analogs for prostate and liver cancer therapy |
Q28576040 | Prolactin blocks nuclear translocation of VDR by regulating its interaction with BRCA1 in osteosarcoma cells |
Q42272357 | Protein-disulfide isomerase-associated 3 (Pdia3) mediates the membrane response to 1,25-dihydroxyvitamin D3 in osteoblasts |
Q42806198 | RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells |
Q40503211 | Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative |
Q35020565 | Simulated microgravity inhibits L-type calcium channel currents partially by the up-regulation of miR-103 in MC3T3-E1 osteoblasts |
Q39150840 | Stable expression of human VDR in murine VDR-null cells recapitulates vitamin D mediated anti-cancer signaling. |
Q27663940 | Structural basis of the histidine-mediated vitamin D receptor agonistic and antagonistic mechanisms of (23S)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone |
Q35758044 | The Effect of Vitamin D3 Alone and Mixed With IFN-γ on Tachyzoites of Toxoplasma gondii (RH Strain) Proliferation and Nitric Oxide (NO) Production in Infected Macrophages of BALB/C Mice |
Q33232265 | The establishment of a HeLa cell demonstrating rapid mitogen-activated protein kinase phosphorylation in response to 1alpha,25-dihydroxyvitamin D3 by stable transfection of a chick skeletal muscle cDNA library |
Q40522062 | The functional consequences of cross-talk between the vitamin D receptor and ERK signaling pathways are cell-specific |
Q36948170 | The lipid messenger OEA links dietary fat intake to satiety. |
Q35891324 | The role of the vitamin D receptor and ERp57 in photoprotection by 1α,25-dihydroxyvitamin D3 |
Q34250790 | Vitamin D and bone |
Q36973933 | Vitamin D and human health: lessons from vitamin D receptor null mice. |
Q21195200 | Vitamin D and the mammary gland: a review on its role in normal development and breast cancer |
Q36351694 | Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation |
Q47581707 | Vitamin D levels in a paediatric population of normal weight and obese subjects |
Q35135698 | Vitamin D receptor (VDR) regulation of voltage-gated chloride channels by ligands preferring a VDR-alternative pocket (VDR-AP) |
Q39992307 | Vitamin D receptor-dependent 1 alpha,25(OH)2 vitamin D3-induced anti-apoptotic PI3K/AKT signaling in osteoblasts |
Q37056390 | Vitamin D, the renin-angiotensin system, and insulin resistance |
Q82953601 | Vitamin D3 and the immune system: maintaining the balance in health and disease |
Q28069486 | Vitamin D3 for the Treatment of Epilepsy: Basic Mechanisms, Animal Models, and Clinical Trials |
Q38040463 | Vitamin D: an overview of its role in skeletal muscle physiology in children and adolescents. |
Q35207472 | Vitamin d, sunlight and prostate cancer risk |
Search more.